Post-publication Peer Review (P3R) is an online forum for ongoingreview peer review. To submit a P3R please go to the article you wish to respond to and click on the link that reads "P3Rs: Submit a Response." Submission of P3Rs are open to all health care professionals and experts in related fields.

Post-publication Peer Reviews to:

ARTICLE:
Mike Thomas, Vasilisa Sazonov Kocevar, Qiaoyi Zhang, Donald D. Yin, and David Price
Asthma-Related Health Care Resource Use Among Asthmatic Children With and Without Concomitant Allergic Rhinitis
Pediatrics 2005; 115: 129-134 [Abstract] [Full text] [PDF]
*P3Rs: Submit a response to this article

P3Rs published:

[Read P3R] Allergic Rhinitis/Asthma Patients Incur Greater Cost -Now What?
Steve Grabosky   (8 January 2005)

Allergic Rhinitis/Asthma Patients Incur Greater Cost -Now What? 8 January 2005
Top
Steve Grabosky,
Laboratorian
ASCP

Send letter to journal:
Re: Allergic Rhinitis/Asthma Patients Incur Greater Cost -Now What?

mgrabosk{at}yahoo.com Steve Grabosky

Since the study group identified incurs higher cost, why not use the ImmunoCAP test to screen? It seems that clinicians and patients would benefit alike to determine if the rhinitis seen was indeed allergic. It's true that all rhinitis is a risk factor for asthma but that the allergic group deserves a more aggressive workup by primary care and a possible referral to a specialist. Which rhinitis group should get this treatment? Differentiate the group with a reliable blood test, then make the decision. Dr. Sampson's studies have demonstrated it's reliability. Further testing can be done in the specialist's office.